Back to Results
First PageMeta Content
Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Antiretroviral drug / Abacavir / Reverse-transcriptase inhibitor / Nevirapine / Efavirenz / Patent / Raltegravir / Chemistry / Organic chemistry / Organofluorides


ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL
Add to Reading List

Document Date: 2015-04-20 05:17:21

Open Document

File Size: 338,44 KB

Share Result on Facebook
UPDATE